---
title: "Novartis AG (NOVN) Gets a Hold from DZ BANK AG"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293552423.md"
description: "DZ BANK AG analyst Elmar Kraus maintained a Hold rating on Novartis AG (NOVN). The stock closed at CHF125.34. While Barclays also issued a Hold, Citi maintained a Buy rating on the healthcare company."
datetime: "2026-07-23T03:15:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293552423.md)
  - [en](https://longbridge.com/en/news/293552423.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293552423.md)
generator: "portal-rs"
---

# Novartis AG (NOVN) Gets a Hold from DZ BANK AG

DZ BANK AG analyst Elmar Kraus maintained a Hold rating on Novartis AG yesterday. The company’s shares closed yesterday at CHF125.34.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Kraus covers the Healthcare sector, focusing on stocks such as Pfizer, AstraZeneca, and GlaxoSmithKline. According to TipRanks, Kraus has an average return of 10.2% and a 69.44% success rate on recommended stocks. 

In addition to DZ BANK AG, Novartis AG also received a Hold from Barclays’s James Gordon CFA in a report issued yesterday. However, on the same day, Citi maintained a Buy rating on Novartis AG (Six Swiss: NOVN).

### Related Stocks

- [NVS.US](https://longbridge.com/en/quote/NVS.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [GSK.UK](https://longbridge.com/en/quote/GSK.UK.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [NOT.DE](https://longbridge.com/en/quote/NOT.DE.md)
- [GSK.WI.US](https://longbridge.com/en/quote/GSK.WI.US.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent](https://longbridge.com/en/news/295810760.md)
- [US families, healthcare providers under strain after Trump crackdown on Haitian immigrants](https://longbridge.com/en/news/296335867.md)
- [Visa, Lockheed Martin And A Health Care Stock On CNBC’s ‘Final Trades’](https://longbridge.com/en/news/296127265.md)
- [BLS data shows fastest-growing jobs through 2034 led by clean energy, healthcare, and tech](https://longbridge.com/en/news/296263775.md)
- [Ocular Therapeutix Earns Buy Rating as Axpaxli Differentiation and LUGANO TKI Data Bolster Confidence in Lead Asset](https://longbridge.com/en/news/296129081.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**